Works matching IS 09650407 AND DT 2020 AND VI 28 AND IP 4
Results: 10
Sulforaphane: Expected to Become a Novel Antitumor Compound.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 439, doi. 10.3727/096504020X15828892654385
- By:
- Publication type:
- Article
The AKT/GSK3-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 423, doi. 10.3727/096504020X15877284857868
- By:
- Publication type:
- Article
Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 409, doi. 10.3727/096504020X15868639303417
- By:
- Publication type:
- Article
miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 399, doi. 10.3727/096504020X15864296270581
- By:
- Publication type:
- Article
Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 385, doi. 10.3727/096504020X15861709922491
- By:
- Publication type:
- Article
Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 371, doi. 10.3727/096504020X15853075736554
- By:
- Publication type:
- Article
miR-4792 Inhibits Acute Myeloid Leukemia Cell Proliferation and Invasion and Promotes Cell Apoptosis by Targeting Kindlin-3.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 357, doi. 10.3727/096504020X15844389264424
- By:
- Publication type:
- Article
EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 345, doi. 10.3727/096504020X15834065061807
- By:
- Publication type:
- Article
ERRATUM.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma.
- Published in:
- Oncology Research, 2020, v. 28, n. 4, p. 331, doi. 10.3727/096504020X15825405463920
- By:
- Publication type:
- Article